
Charanjit Aulakh
Examiner (ID: 11601)
| Most Active Art Unit | 1625 |
| Art Unit(s) | 1625, 1612, 1203, 1621 |
| Total Applications | 3765 |
| Issued Applications | 2855 |
| Pending Applications | 383 |
| Abandoned Applications | 582 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9074611
[patent_doc_number] => 08552190
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2013-10-08
[patent_title] => 'Tristhiourea tripodal metal complexes'
[patent_app_type] => utility
[patent_app_number] => 13/769233
[patent_app_country] => US
[patent_app_date] => 2013-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4238
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13769233
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/769233 | Tristhiourea tripodal metal complexes | Feb 14, 2013 | Issued |
Array
(
[id] => 10670831
[patent_doc_number] => 20160016977
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-21
[patent_title] => 'ALKALINE EARTH METAL-COMPLEXED METAL BISAMIDES'
[patent_app_type] => utility
[patent_app_number] => 14/378998
[patent_app_country] => US
[patent_app_date] => 2013-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5394
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14378998
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/378998 | Alkaline earth metal-complexed metal bisamides | Feb 12, 2013 | Issued |
Array
(
[id] => 10213943
[patent_doc_number] => 20150098935
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-04-09
[patent_title] => 'Induction of highly specific antibodies to a hapten but not to a carrier peptide by immunization'
[patent_app_type] => utility
[patent_app_number] => 14/377126
[patent_app_country] => US
[patent_app_date] => 2013-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 13504
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14377126
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/377126 | Induction of highly specific antibodies to a hapten but not to a carrier peptide by immunization | Feb 7, 2013 | Issued |
Array
(
[id] => 9923134
[patent_doc_number] => 08981098
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-03-17
[patent_title] => 'Process for the preparation of morphine analogs via the reaction of organometallic reagents with an oxazolidine derived from morphinans'
[patent_app_type] => utility
[patent_app_number] => 14/374397
[patent_app_country] => US
[patent_app_date] => 2013-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9501
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14374397
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/374397 | Process for the preparation of morphine analogs via the reaction of organometallic reagents with an oxazolidine derived from morphinans | Jan 29, 2013 | Issued |
Array
(
[id] => 8951252
[patent_doc_number] => 20130197033
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-01
[patent_title] => 'PAROXETINE DERIVATIVE'
[patent_app_type] => utility
[patent_app_number] => 13/752638
[patent_app_country] => US
[patent_app_date] => 2013-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6824
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13752638
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/752638 | Paroxetine derivative | Jan 28, 2013 | Issued |
Array
(
[id] => 9454525
[patent_doc_number] => 08715529
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2014-05-06
[patent_title] => 'Synthesis and applications of triazaborolopyridinium compounds and substituted triazaborolopyridinium compounds and methods of use'
[patent_app_type] => utility
[patent_app_number] => 13/747674
[patent_app_country] => US
[patent_app_date] => 2013-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 18966
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13747674
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/747674 | Synthesis and applications of triazaborolopyridinium compounds and substituted triazaborolopyridinium compounds and methods of use | Jan 22, 2013 | Issued |
Array
(
[id] => 10026059
[patent_doc_number] => 09067946
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-06-30
[patent_title] => 'Flindersia alkaloids, derivatives and analogs: compositions and methods for producing the same'
[patent_app_type] => utility
[patent_app_number] => 13/744884
[patent_app_country] => US
[patent_app_date] => 2013-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 5850
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13744884
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/744884 | Flindersia alkaloids, derivatives and analogs: compositions and methods for producing the same | Jan 17, 2013 | Issued |
Array
(
[id] => 9350473
[patent_doc_number] => 08669364
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-03-11
[patent_title] => 'Tridentate platinum (II) complexes'
[patent_app_type] => utility
[patent_app_number] => 13/745111
[patent_app_country] => US
[patent_app_date] => 2013-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 20
[patent_no_of_words] => 9861
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13745111
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/745111 | Tridentate platinum (II) complexes | Jan 17, 2013 | Issued |
Array
(
[id] => 9844338
[patent_doc_number] => 08946254
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-02-03
[patent_title] => 'Bivalent ligands for the treatment of neurological disorders'
[patent_app_type] => utility
[patent_app_number] => 14/371075
[patent_app_country] => US
[patent_app_date] => 2013-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 18
[patent_no_of_words] => 25530
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14371075
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/371075 | Bivalent ligands for the treatment of neurological disorders | Jan 9, 2013 | Issued |
Array
(
[id] => 8989778
[patent_doc_number] => 20130217059
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-22
[patent_title] => 'FLUORESCENT DYES'
[patent_app_type] => utility
[patent_app_number] => 13/733324
[patent_app_country] => US
[patent_app_date] => 2013-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 15728
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13733324
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/733324 | Fluorescent dyes | Jan 2, 2013 | Issued |
Array
(
[id] => 8896922
[patent_doc_number] => 08476443
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-07-02
[patent_title] => 'Fluorescent dyes'
[patent_app_type] => utility
[patent_app_number] => 13/733350
[patent_app_country] => US
[patent_app_date] => 2013-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 11879
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13733350
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/733350 | Fluorescent dyes | Jan 2, 2013 | Issued |
Array
(
[id] => 9355570
[patent_doc_number] => 08674102
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-03-18
[patent_title] => 'Fluorescent dyes'
[patent_app_type] => utility
[patent_app_number] => 13/733239
[patent_app_country] => US
[patent_app_date] => 2013-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 27
[patent_no_of_words] => 15729
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13733239
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/733239 | Fluorescent dyes | Jan 2, 2013 | Issued |
Array
(
[id] => 9839963
[patent_doc_number] => 20150032045
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-29
[patent_title] => 'PHOTOLABILE COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 14/368114
[patent_app_country] => US
[patent_app_date] => 2012-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 34
[patent_no_of_words] => 34565
[patent_no_of_claims] => 73
[patent_no_of_ind_claims] => 23
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14368114
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/368114 | PHOTOLABILE COMPOUNDS | Dec 20, 2012 | Abandoned |
Array
(
[id] => 8925436
[patent_doc_number] => 20130181196
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-07-18
[patent_title] => 'COMPOUNDS AND ORGANIC ELECTRONIC DEVICE USING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 13/725170
[patent_app_country] => US
[patent_app_date] => 2012-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 13443
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13725170
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/725170 | Compounds and organic electronic device using the same | Dec 20, 2012 | Issued |
Array
(
[id] => 9799820
[patent_doc_number] => 20150011764
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-08
[patent_title] => 'HETEROLEPTIC LIGHT-EMITTING COMPLEXES'
[patent_app_type] => utility
[patent_app_number] => 14/369450
[patent_app_country] => US
[patent_app_date] => 2012-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 8640
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14369450
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/369450 | Heteroleptic light-emitting complexes | Dec 19, 2012 | Issued |
Array
(
[id] => 10975650
[patent_doc_number] => 20140378685
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-12-25
[patent_title] => 'PREPARATION OF HETEROLEPTIC METAL COMPLEXES'
[patent_app_type] => utility
[patent_app_number] => 14/369466
[patent_app_country] => US
[patent_app_date] => 2012-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7113
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14369466
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/369466 | PREPARATION OF HETEROLEPTIC METAL COMPLEXES | Dec 19, 2012 | Abandoned |
Array
(
[id] => 9831945
[patent_doc_number] => 08940761
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-01-27
[patent_title] => '[1,2,4]triazolopyridines and their use as phosphodiesterase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 14/361356
[patent_app_country] => US
[patent_app_date] => 2012-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7702
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14361356
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/361356 | [1,2,4]triazolopyridines and their use as phosphodiesterase inhibitors | Dec 18, 2012 | Issued |
Array
(
[id] => 9832078
[patent_doc_number] => 08940895
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-01-27
[patent_title] => 'Heterocyclic fluorescent dyes and method of production thereof'
[patent_app_type] => utility
[patent_app_number] => 14/363104
[patent_app_country] => US
[patent_app_date] => 2012-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11283
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14363104
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/363104 | Heterocyclic fluorescent dyes and method of production thereof | Dec 16, 2012 | Issued |
Array
(
[id] => 10057261
[patent_doc_number] => 09096606
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-08-04
[patent_title] => 'Quarternized buprenorphine analogs'
[patent_app_type] => utility
[patent_app_number] => 14/363386
[patent_app_country] => US
[patent_app_date] => 2012-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39022
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14363386
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/363386 | Quarternized buprenorphine analogs | Dec 6, 2012 | Issued |
Array
(
[id] => 9772861
[patent_doc_number] => 20140296525
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-02
[patent_title] => 'PROCESS FOR RECOVERY OF NALMEFENE HYDROCHLORIDE'
[patent_app_type] => utility
[patent_app_number] => 14/294707
[patent_app_country] => US
[patent_app_date] => 2012-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4660
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14294707
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/294707 | Process for recovery of nalmefene hydrochloride | Dec 5, 2012 | Issued |